Latest Pharmaceutical, BioTechnology, Clinical Trials and Biosimilars Industry News

FDA Approves Octapharma’s Octagam® 10% for Adult Dermatomyositis

The U.S. Food and Drug Administration (FDA) has granted approval to Octapharma USA for Octagam® 10% [Immune Globulin Intravenous (Human)].

Ninonasal® Antigen Self-Tests Made in France

NG Biotech presents Ninonasal®, the COVID-19 antigen self-test that´s detecting Delta and Epsilon variants. Ninonasal® has obtained the CE mark and can now be marketed across Europe.

Genexa, the World’s First and Only Clean Medicine Company

Genexa, the world’s first clean, over-the-counter pharmaceutical company, has just completed its unprecedented $60 million Series A of funding to advance its market leadership in this emerging space. Marking a seminal development in the consumer healthcare industry,

New High Potency Synthetic Opioid Linked to Overdose Deaths Across United States

A novel synthetic opioid with purported potency greater than fentanyl has emerged in the United States and is linked to a growing number of overdose deaths across at least five states.

The First SLIM-Based High-Resolution Ion Mobility (HRIM) Product to Accelerate Biotherapeutic Drug Development and Multiomic Biomarker Discovery

MOBILion Systems Inc. has launched of its first commercial High-Resolution Ion Mobility (HRIM) product, MOBIE, which addresses characterization challenges faced during biopharmaceutical drug development and quality monitoring. MOBIE provides fast..

Immunicom Presents Promising Clinical Trial Data at AACR in Late-Stage Breast Cancer Patients Treated with Novel Non-Pharmaceutical Immunotherapy

Immunicom, Inc., a global biotech company that is redefining immuno-oncology with breakthrough non-pharmaceutical subtractive immunotherapy treatments designed to preserve quality-of-life while being treated, presented preliminary data from its late-stage..